Viewing nowCombinationDuoPito 10/10 mg
Atorvastatin Calcium Trihydrate 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.

MFDS item code 202101420 · Approved 2021.02.18
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication helps lower total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL-cholesterol levels, and increase HDL-cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia, and it is used as an adjunct to diet. Additionally, it is indicated as an adjunct treatment for patients with homozygous familial hypercholesterolemia when other treatments are insufficient. Before taking this medication, secondary causes such as diabetes or hypothyroidism should be evaluated and treated if necessary. Lipid tests should include total cholesterol, LDL, HDL, and triglycerides, with additional testing required if triglycerides are significantly elevated. For patients with acute coronary events, lipid levels should be measured upon hospitalization and LDL-lowering treatment should be initiated at discharge. This medication is effective in improving blood lipid levels when used alongside proper lifestyle habits.
Administer this medication once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medication. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), an initial dose of 10/40mg once daily is recommended. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. Administer this medication as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not useful.
This medication carries a risk of serious muscle problems, so if severe muscle pain or weakness occurs suddenly, the patient should inform their doctor immediately. Especially if there are conditions such as severe infections, major surgery, trauma, or severe metabolic abnormalities or electrolyte imbalances, this medication may need to be temporarily discontinued. Women who are pregnant or nursing, or individuals with known allergies to any of its components, severe liver dysfunction, or muscle diseases should not use this medication. Also, patients with certain liver diseases or abnormally high serum liver enzyme levels should not be administered this medication. Patients with a history of alcohol abuse or liver disease, those with impaired kidney function or a history of hypothyroidism or muscle disease should use this medication with caution. Elderly patients over 70 years old are also at a higher risk for muscle-related issues, so caution is advised. Moreover, patients taking fibrate class medications should be careful as well. Regular liver function tests should be performed during treatment with this medication, and if any symptoms of liver dysfunction appear, treatment should be stopped immediately. Women who are pregnant or may become pregnant should use appropriate contraceptive methods, and if pregnancy is confirmed, this medication should be discontinued immediately. Nursing mothers are also advised against taking this medication for the safety of their infants. This medication has not been established as safe and effective in children and is not recommended. While elderly patients are at a higher risk for muscle-related problems and should exercise caution during use, dosage adjustment is not strictly necessary. Patients with impaired kidney function should be closely monitored for the risk of muscle issues. When taking this medication with other drugs, the risk of side effects may increase due to interactions, particularly with medications metabolized in the liver or those that can affect muscles, so patients should consult their doctor beforehand. Patients may experience dizziness, muscle pain, or abdominal pain during treatment, and caution should be exercised when driving or operating machinery. In case of overdose, there is no specific antidote, and appropriate care and supportive treatment should be sought based on symptoms, while monitoring liver function and muscle damage.
muscle pain, abdominal pain, elevation of liver enzymes, increased ALT, increased AST, musculoskeletal pain, dizziness, cough, nausea, vomiting, joint pain, muscle weakness, hyperkalemia, bronchitis, sinusitis, flushing, intracranial aneurysm, restless legs syndrome, depression, bronchiolitis, dental abscess, vestibular neuritis, bradycardia, hypotension, anemia, hernia, vitamin D deficiency, gastric polyps, duodenal polyps, duodenitis, jaundice, erectile dysfunction, breast mass, skin mass, ingrowing toenail, thyroid adenoma, weakness, lethargy, chest pain, peripheral edema, fatigue, fever, rhinitis, hyperglycemia, hypoglycemia, weight gain, loss of appetite, constipation, abdominal bloating, indigestion, diarrhea, pharyngeal and laryngeal pain, nosebleed, insomnia, nightmares, headache, sensory disturbance, decreased sensation, taste disturbance, amnesia, peripheral neuropathy, muscle cramps, joint swelling, back pain, neck pain, muscle fatigue, complications from rupture, myopathy, myositis, rhabdomyolysis, tendon disorders, muscle rupture, lupus-like syndrome, immune-mediated necrotizing myopathy, thrombocytopenia, allergic reaction, anaphylaxis, hepatitis, cholestasis, liver failure, blurred vision, visual impairment, tinnitus, hearing loss, urticaria, skin rash, itching, hair loss, vascular edema, polymorphic erythema, mucocutaneous syndrome, toxic epidermal necrolysis, gynecomastia, low back pain, upper abdominal pain, gastritis, dry mouth, epigastric discomfort, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, vomiting, cholelithiasis, cholecystitis, drug-induced liver injury, mucocutaneous syndrome, toxic epidermal necrolysis, drug reactions with eosinophilia and systemic symptoms, polymorphic erythema, fatigue, chest discomfort, edema, myasthenia, generalized edema, diabetic neuropathy, tremors, upper respiratory infection, conjunctival injection, erectile dysfunction, urinary tract infection, frequent urination, cystitis, hematuria, dysuria, kidney stones, nocturia, epididymitis, breast cyst, vaginal bleeding, albuminuria, breast enlargement, cervical discharge, nephritis, urinary incontinence, urinary retention, urgency, abnormal ejaculation, uterine bleeding, discolored urine, hypoglycemia, hyperglycemia, increased appetite, vasomotor edema, chest pain, angina, facial swelling, fever, neck stiffness, generalized edema, amblyopia, dry eye, refractive error, ocular hemorrhage, hearing loss, glaucoma, hypogeusia, ageusia, leukopenia, decreased testosterone, increased cholinesterase, elevated TSH, elevated ACTH, decreased aldosterone, increased potassium, elevated BUN, cerebral infarction, palpitations, tachycardia, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it should be kept in a cool place below 30 degrees Celsius to maintain its efficacy.
White to off-white, biconvex, oval film-coated tablet
30 tablets/box [10 tablets/PVC × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Trihydrate 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.